- Home
- TRS vs NVAX Comparison
TRS vs NVAX Comparison
Compare TRS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- NVAX
- Stock Information
- Founded
- TRS 1986
- NVAX 1987
- Country
- TRS United States
- NVAX United States
- Employees
- TRS N/A
- NVAX N/A
- Industry
- TRS Industrial Specialties
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRS Industrials
- NVAX Health Care
- Exchange
- TRS Nasdaq
- NVAX Nasdaq
- Market Cap
- TRS 1.5B
- NVAX 1.3B
- IPO Year
- TRS 2007
- NVAX 1995
- Fundamental
- Price
- TRS $37.36
- NVAX $8.90
- Analyst Decision
- TRS Strong Buy
- NVAX Buy
- Analyst Count
- TRS 2
- NVAX 7
- Target Price
- TRS $45.00
- NVAX $14.29
- AVG Volume (30 Days)
- TRS 460.8K
- NVAX 4.5M
- Earning Date
- TRS 10-28-2025
- NVAX 11-11-2025
- Dividend Yield
- TRS 0.43%
- NVAX N/A
- EPS Growth
- TRS N/A
- NVAX N/A
- EPS
- TRS 0.91
- NVAX 2.54
- Revenue
- TRS $973,840,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- TRS $11.03
- NVAX $60.81
- Revenue Next Year
- TRS $6.13
- NVAX N/A
- P/E Ratio
- TRS $41.08
- NVAX $3.50
- Revenue Growth
- TRS 6.72
- NVAX 9.22
- 52 Week Low
- TRS $19.33
- NVAX $5.01
- 52 Week High
- TRS $40.34
- NVAX $13.61
- Technical
- Relative Strength Index (RSI)
- TRS 44.34
- NVAX 63.29
- Support Level
- TRS $36.73
- NVAX $8.95
- Resistance Level
- TRS $38.07
- NVAX $9.05
- Average True Range (ATR)
- TRS 0.86
- NVAX 0.41
- MACD
- TRS -0.38
- NVAX 0.05
- Stochastic Oscillator
- TRS 14.13
- NVAX 80.50
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.